Healthy Extracts Inc. Reports Revenue Growth but Faces Rising Costs and Expanding Deficit in Q1 2025

Healthy Extracts Inc. (PINK: HYEX) has released its quarterly financial results for the three months ending March 31, 2025, revealing mixed performance in various aspects of its income statement.

Positive Aspects:

• Revenue Growth: Revenue rose to $931,280, up 35% from $688,786 in Q1 2024.
• Gross Profit: Gross profit increased to $424,985 from $408,358, marking a 4% rise.
• Other Income (Expenses): Other expenses decreased to $(290,011) from $(799,185), showing a positive trend in financial management.
• Net Loss Improvement: The net loss narrowed to $(398,860), compared to $(861,259) in the same quarter last year, reflecting improving operational efficiency.

Negative Aspects:

• Cost of Revenues: Increased to $506,295, a 81% rise from $280,428 in Q1 2024, affecting gross margins.
• Operating Expenses: Operating expenses rose to $533,833, representing a 13% increase from $470,431 a year earlier, primarily due to higher advertising costs.
• Inventory Management: Inventory declined by $218,589, indicating potential supply chain or demand issues that need addressing.
• Accumulated Deficit: The accumulated deficit widened to $(19,639,204), increasing concern over long-term financial health.

Key Statistics:

• Total Current Assets: $1,480,680 as of March 31, 2025, down from $1,659,388.
• Total Assets: Increased slightly to $2,411,485 from $2,377,973.
• Total Liabilities: Increased significantly to $2,350,977 compared to $1,967,596.
• Cash Position: Cash on hand reached $118,798, a modest increase of $6,778 from the end of 2024.
• Shares Outstanding: The company had 2,989,406 shares issued as of March 31, 2025.

Despite the notable revenue growth and narrowing losses, Healthy Extracts Inc. still must tackle rising costs and operational challenges that threaten its financial stability moving forward. Investors should key in on the company's ability to manage expenses and improve its balance sheet in the upcoming quarters.